KIMERA LABS

In News

Kimera Labs Implements ISO 9001:2015, ISO 13485:2016, and ISO 22716:2007 Across Its Miramar Manufacturing Facility - StreetInsider

StreetInsider - Jun 01, 2026

Kimera® Labs Named Semifinalist in $101 Million XPRIZE Healthspan Competition for Pioneering Innovations in Healthy Aging - PR Newswire

PR Newswire - May 12, 2025

FDA Warns Exosome Maker for Marketing Outside Its IND - MedPage Today

MedPage Today - Jan 22, 2024

Kimera Labs Introduces the Ross Unit, a Standard Measurement for Exosome Potency and Characterization - BioInformant

BioInformant - Mar 11, 2021

Kimera® Labs Files First FDA Investigational New Drug (IND) Application Using XoGlo® for Treatment of ARDS Secondary to COVID-19 - BioSpace

BioSpace - Aug 18, 2020

Limited Reporting of Adverse Events Tied to Regenerative Treatments Leaves Consumers Vulnerable - The Pew Charitable Trusts

The Pew Charitable Trusts - Jul 31, 2020

Kimera Labs Files Lawsuit against Exocel Bio Inc, CEO for Alleged Theft of Trade Secrets - Dentistry Today

Dentistry Today - Apr 22, 2022

Kimera Labs to ship products leveraging CSafe Global’s container - Packaging Gateway

Packaging Gateway - Apr 14, 2020

Kimera Labs Announces New Standard Measurement For Exosome Potency, Characterization - PR Newswire

PR Newswire - Mar 11, 2021

Doctor Sued Over Stem Cell Treatments - MedPage Today

MedPage Today - Mar 17, 2022

Exosome Therapeutics Market Size to Hit USD 4,564.32 Thousand by 2035 - Precedence Research

Precedence Research - Oct 06, 2025

Current Snapshot of the Exosome Market – Who’s Who and Who’s Doing What? - BioInformant

BioInformant - May 17, 2020

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment